Acupuncture and Laser Acupoint Treatment on Hypertension

The recruitment status of this study is unknown because the information has not been verified recently.

Verified October 2008 by Logan College of Chiropractic. Recruitment status was Recruiting

First Received on April 10, 2007. Last Updated on January 20, 2010 History of Changes

Sponsor:	Logan College of Chiropractic
Information provided by:	Logan College of Chiropractic
ClinicalTrials.gov Identifier:	NCT00459680

Purpose

To determine the effect of acupuncture and laser acupuncture point treatment on hypertensive subjects.

Condition	Intervention	Phase
Hypertension	Device: Laser acupoint treatment Procedure: Acupuncture	Phase I

Study Type:	Interventional
Study Design:	Allocation: Randomized Endpoint Classification: Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Treatment
Official Title:	Acupuncture and Laser Acupoint Treatment on Hypertension

Resource links provided by NLM:

MedlinePlus related topics: Acupuncture Acute Bronchitis High Blood Pressure

U.S. FDA Resources

Further study details as provided by Logan College of Chiropractic:

Primary Outcome Measures:

Blood pressure [ Time Frame: Pretreatment then at 2 and 4 weeks ] [ Designated as safety issue: No ]

Estimated Enrollment:	30
Study Start Date:	February 2008
Estimated Study Completion Date:	June 2009
Estimated Primary Completion Date:	January 2009 (Final data collection date for primary outcome measure)

Arms	Assigned Interventions
Experimental: Acupuncture	Procedure: Acupuncture Needle acupuncture on ST36 and LI11.
Experimental: Laser Acupoint	Device: Laser acupoint treatment Laser Other Name: Laser

Detailed Description:

The specific aims of the study are to test the effectiveness of acupuncture and laser acupoint on hypertension. The hypothesis is: the stimulation of a pattern of acupoints with acupuncture and laser will result in significant reductions in blood pressure. The points that are going to be used for the study are: Zusanli (St36), Tianshu (St25), Quchi (LI11).

Eligibility

Ages Eligible for Study:	18 Years to 70 Years
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No

Criteria

Inclusion Criteria:

Male or female over 18 and under 70 years of age with hypertension (blood pressure over 140/90 mmhg).

Exclusion Criteria:

Individuals with heart, kidney, thyroid disorders, diabetes, chronic disease or illness, neurological diseases, skin or bleeding disorders, and currently taking drugs or medications will not be recruited in the study. A health history questionnaire will be used to screen the subjects.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00459680

Locations

United States, Missouri
Logan College of Chiropractic	Recruiting
Chesterfield, Missouri, United States, 63017
Contact: John Zhang, MD, PhD 636-230-1920 john.zhang@logan.edu

Sponsors and Collaborators

Logan College of Chiropractic

Investigators

Principal Investigator:

John Zhang, MD. PhD

Logan College of Chiropractic

More Information

No publications provided

Responsible Party:	John Zhang, Logan College of Chiropractic
ClinicalTrials.gov Identifier:	NCT00459680 History of Changes
Other Study ID Numbers:	LCC-05-06
Study First Received:	April 10, 2007
Last Updated:	January 20, 2010
Health Authority:	United States: Institutional Review Board

Keywords provided by Logan College of Chiropractic:

hypertension
acupuncture
laser

Additional relevant MeSH terms:

Hypertension
Vascular Diseases
Cardiovascular Diseases

ClinicalTrials.gov processed this record on February 12, 2012